Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types,
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E …

Background Invasive lobular breast cancer (ILC) is the second most common type of breast
cancer after invasive breast cancer of no special type (NST), representing up to 15% of all …

Aims Oncotype DX recurrence score (RS) is a clinically validated assay, which predicts the
likelihood of disease recurrence in oestrogen receptor‐positive/HER2‐negative …

Background Mixed invasive ductal lobular carcinoma (mDLC) remains a poorly understood
subtype of breast cancer composed of coexisting ductal and lobular components. Methods …

BACKGROUND Breast cancer and its treatment can have an impact on health-related
quality of life and survival. Tumour profiling tests aim to identify whether or not women need …

Background Oncotype DX Recurrence Score (RS) has been widely used to predict
chemotherapy benefits in patients with estrogen receptor-positive breast cancer. Studies …

The 21-gene recurrence score (RS) is prognostic for recurrence and predictive of
chemotherapy benefit in early estrogen receptor-positive (ER+) HER2-negative (HER2-) …

Abstract Background/Objective Cancers classified as “special histologic subtypes” are felt to
have a good prognosis. We used the 21-gene Oncotype DX Breast Recurrence Score® …

Background/purpose The 21-gene recurrence score (RS) assay predicts the likelihood of
distant recurrence and chemotherapy benefit in early-stage, estrogen receptor (ER)-positive …

Long non‑coding RNA (lncRNA) H19 has been suggested to serve important roles in the
progression of gastric cancer (GC); however, the mechanism involved is largely unknown …